FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1210-1211 October 10, 2002 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Inhaled corticosteroids are increasingly being used for the prophylactic treatment of asthma in children. The benefits have been well documented; however, the potential risk of growth suppression has not been fully investigated. Recent follow-up evaluations have found that final height is within the genetic target-height range in children in whom inhaled corticosteroids were prescribed for up to nine years.^1,2 Many methodologic flaws, however, may limit the utility of follow-up growth data in children receiving inhaled corticosteroids. Most important, no measures of compliance were reported in one of these studies.¹ In the other, compliance was checked at each . . . [Full Text of this Article]

This article has been cited by other articles:

• Priftis, K. N., Papadimitriou, A., Gatsopoulou, E., Yiallouros, P. K., Fretzayas, A., Nicolaidou, P. (2006). The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children. Eur Respir J 27: 316-320 [Abstract] [Full Text]